IPTACOPAN HYDROCHLORIDE, IPTACOPAN
CLNP023B12001B
Approved small_molecule active
Quick answer
IPTACOPAN HYDROCHLORIDE, IPTACOPAN for C3 Glomerulopathy or idiopathic immune-complex membranoproliferative glomerulonephritis is a Approved program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- C3 Glomerulopathy or idiopathic immune-complex membranoproliferative glomerulonephritis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active